Published in Proc Natl Acad Sci U S A on August 01, 1989
Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J Virol (1994) 6.67
Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J Virol (1993) 6.11
Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J Virol (1992) 6.07
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J Virol (1992) 5.85
Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J Virol (1997) 4.08
Comparison of two host cell range variants of feline immunodeficiency virus. J Virol (1990) 2.98
Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein. J Virol (1995) 2.76
Specificity and sequence requirements for interactions between various retroviral Gag proteins. J Virol (1994) 2.50
Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J Virol (1990) 2.40
Going wild: lessons from naturally occurring T-lymphotropic lentiviruses. Clin Microbiol Rev (2006) 2.28
Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev (1995) 2.06
In vivo lymphocyte tropism of feline immunodeficiency virus. J Virol (1993) 2.00
Characterization of the minimal DNA-binding domain of the HIV integrase protein. Nucleic Acids Res (1994) 1.98
Distinct subsets of retroviruses encode dUTPase. J Virol (1992) 1.80
A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein. J Virol (1991) 1.72
Characterization of human immunodeficiency virus type 1 Vif particle incorporation. J Virol (1996) 1.69
Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus. J Virol (1989) 1.63
Isolation of novel human endogenous retrovirus-like elements with foamy virus-related pol sequence. J Virol (1995) 1.62
Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J Virol (1994) 1.59
Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection. J Virol (1990) 1.59
Identification of a feline immunodeficiency virus gene which is essential for cell-free virus infectivity. J Virol (1992) 1.59
Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J Virol (1999) 1.58
Unintegrated lentivirus DNA persistence and accessibility to expression in nondividing cells: analysis with class I integrase mutants. J Virol (2004) 1.56
Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins. J Virol (1990) 1.56
Genetic diversity of feline immunodeficiency virus: dual infection, recombination, and distinct evolutionary rates among envelope sequence clades. J Virol (1997) 1.55
Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor. J Virol (2001) 1.54
Feline immunodeficiency virus infects both CD4+ and CD8+ T lymphocytes. J Virol (1991) 1.49
CXCR4 is required by a nonprimate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent, and feline cells. J Virol (1998) 1.46
Identification of proteolytic processing sites within the Gag and Pol polyproteins of feline immunodeficiency virus. J Virol (1993) 1.46
Plus-strand origin for human immunodeficiency virus type 1: implications for integration. J Virol (1990) 1.45
Conserved functional organization of the human immunodeficiency virus type 1 and visna virus Rev proteins. J Virol (1991) 1.41
Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine. Proc Natl Acad Sci U S A (1990) 1.39
Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J Virol (1992) 1.38
Genetic and phylogenetic divergence of feline immunodeficiency virus in the puma (Puma concolor). J Virol (1996) 1.36
Activities of the feline immunodeficiency virus integrase protein produced in Escherichia coli. J Virol (1994) 1.35
Proviral burden and infection kinetics of feline immunodeficiency virus in lymphocyte subsets of blood and lymph node. J Virol (1996) 1.31
Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV. Curr HIV Res (2010) 1.29
A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells. J Virol (1995) 1.28
Molecular biology and pathogenesis of animal lentivirus infections. Clin Microbiol Rev (1996) 1.26
Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats. J Virol (1996) 1.23
The role of unintegrated DNA in HIV infection. Retrovirology (2011) 1.23
Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo. Proc Natl Acad Sci U S A (1998) 1.21
Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus. J Virol (1999) 1.20
Nucleotide sequence of feline immunodeficiency virus: classification of Japanese isolates into two subtypes which are distinct from non-Japanese subtypes. J Virol (1995) 1.19
Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original U.S. isolate. J Virol (1991) 1.19
A rat brain mRNA encoding a transcriptional activator homologous to the DNA binding domain of retroviral integrases. Nucleic Acids Res (1991) 1.19
Mapping the encapsidation determinants of feline immunodeficiency virus. J Virol (2002) 1.18
Identification of feline immunodeficiency virus rev gene activity. J Virol (1991) 1.18
Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity. J Virol (1999) 1.18
Replication properties of dUTPase-deficient mutants of caprine and ovine lentiviruses. J Virol (1996) 1.17
Interspecies transmission of feline immunodeficiency virus from the domestic cat to the Tsushima cat (Felis bengalensis euptilura) in the wild. J Virol (1999) 1.15
Isolation and partial characterization of infectious molecular clones of feline immunodeficiency virus obtained directly from bone marrow DNA of a naturally infected cat. J Virol (1992) 1.15
Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C. J Virol (2004) 1.14
Irreversible inhibition of human immunodeficiency virus type 1 integrase by dicaffeoylquinic acids. J Virol (1999) 1.14
B epitopes and selection pressures in feline immunodeficiency virus envelope glycoproteins. J Virol (1993) 1.12
Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants. J Virol (1995) 1.11
Identification of a central DNA flap in feline immunodeficiency virus. J Virol (2001) 1.10
Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats. J Virol (1992) 1.10
Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions. J Virol (2001) 1.08
A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity. J Virol (1994) 1.08
Differential utilization of CD134 as a functional receptor by diverse strains of feline immunodeficiency virus. J Virol (2006) 1.07
Expanded host cell tropism and cytopathic properties of feline immunodeficiency virus strain PPR subsequent to passage through interleukin-2-independent T cells. J Virol (2000) 1.07
Evolution of feline immunodeficiency virus in Felidae: implications for human health and wildlife ecology. Vet Immunol Immunopathol (2008) 1.07
Factors that increase the effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication. J Virol (2004) 1.05
Feline immunodeficiency virus can be experimentally transmitted via milk during acute maternal infection. J Virol (1994) 1.04
Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection. J Virol (2011) 1.04
Molecular mechanisms of FIV infection. Vet Immunol Immunopathol (2008) 1.02
Detection of feline immunodeficiency virus (FIV) nucleic acids in FIV-seronegative cats. J Virol (1992) 1.01
Crystal structure of dUTP pyrophosphatase from feline immunodeficiency virus. Protein Sci (1996) 1.01
Feline immunodeficiency virus OrfA is distinct from other lentivirus transactivators. J Virol (2002) 1.00
A single amino acid substitution in the transmembrane envelope glycoprotein of feline immunodeficiency virus alters cellular tropism. J Virol (1997) 0.99
Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids. J Virol (2010) 0.97
Structural and functional analysis of the visna virus Rev-response element. J Virol (1992) 0.97
Differential cell tropism of feline immunodeficiency virus molecular clones in vivo. J Virol (1999) 0.97
Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope. J Virol (1997) 0.97
Genomic organization, sequence divergence, and recombination of feline immunodeficiency virus from lions in the wild. BMC Genomics (2008) 0.96
Transcription termination and polyadenylation in retroviruses. Microbiol Rev (1993) 0.96
Structure and genetic variability of envelope glycoproteins of two antigenic variants of caprine arthritis-encephalitis lentivirus. J Virol (1991) 0.96
A novel Met-to-Thr mutation in the YMDD motif of reverse transcriptase from feline immunodeficiency virus confers resistance to oxathiolane nucleosides. J Virol (1997) 0.95
Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. Proc Natl Acad Sci U S A (1994) 0.95
Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence. J Virol (2002) 0.95
Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats. J Virol (1996) 0.95
Feline immunodeficiency virus ORF-Ais required for virus particle formation and virus infectivity. J Virol (2003) 0.95
Molecular analysis of the feline immunodeficiency virus protease: generation of a novel form of the protease by autoproteolysis and construction of cleavage-resistant proteases. J Virol (1997) 0.94
Replication properties of clade A/C chimeric feline immunodeficiency viruses and evaluation of infection kinetics in the domestic cat. J Virol (2008) 0.94
Evaluation of feline immunodeficiency virus and feline leukemia virus transmembrane peptides for serological diagnosis. J Clin Microbiol (1992) 0.94
Optimal packaging of FIV genomic RNA depends upon a conserved long-range interaction and a palindromic sequence within gag. J Mol Biol (2010) 0.94
The feline immunodeficiency virus ORF-A gene facilitates efficient viral replication in established T-cell lines and peripheral blood lymphocytes. J Virol (1993) 0.93
SHAPE analysis of the FIV Leader RNA reveals a structural switch potentially controlling viral packaging and genome dimerization. Nucleic Acids Res (2011) 0.93
Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide. J Virol (1994) 0.93
Human gene therapy vectors derived from feline lentiviruses. Vet Immunol Immunopathol (2008) 0.91
Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein. J Virol (2003) 0.91
RNA secondary structure of the feline immunodeficiency virus 5'UTR and Gag coding region. Nucleic Acids Res (2008) 0.90
Feline immunodeficiency virus neuropathogenesis: from cats to calcium. J Neuroimmune Pharmacol (2006) 0.90
Feline immunodeficiency virus Vif localizes to the nucleus. J Virol (2000) 0.90
Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein. J Virol (1995) 0.90
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
"A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. Anal Biochem (1984) 66.58
Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature (1985) 30.62
A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res (1976) 24.00
Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell (1986) 20.08
Nucleotide sequence of the AIDS virus, LAV. Cell (1985) 16.81
Regulation of simian virus 40 transcription: sensitive analysis of the RNA species present early in infections by virus or viral DNA. J Virol (1979) 15.69
Genome organization and transactivation of the human immunodeficiency virus type 2. Nature (1987) 11.79
Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science (1985) 10.97
Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature (1988) 10.69
Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature (1987) 7.96
Signals for ribosomal frameshifting in the Rous sarcoma virus gag-pol region. Cell (1988) 7.14
Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science (1987) 6.56
Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group. Nature (1988) 5.09
Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus. J Virol (1986) 5.05
Sequence at the 3' end of globin mRNA shows homology with immunoglobulin light chain mRNA. Nature (1974) 4.24
Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am J Vet Res (1988) 3.89
Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor. Proc Natl Acad Sci U S A (1987) 3.72
Nucleotide sequence of three isoaccepting lysine tRNAs from rabbit liver and SV40-transformed mouse fibroblasts. Eur J Biochem (1979) 3.59
Nucleotide sequence evidence for relationship of AIDS retrovirus to lentiviruses. Nature (1985) 3.13
Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J Am Vet Med Assoc (1989) 2.97
Fatty acylation of proteins. Annu Rev Cell Biol (1988) 2.92
Nucleotide sequence analysis of equine infectious anemia virus proviral DNA. Virology (1987) 2.19
Feline immunodeficiency virus infection in cats of Japan. J Am Vet Med Assoc (1989) 2.13
Feline immunodeficiency virus infection. Vet Immunol Immunopathol (1989) 2.00
Characterization of a cDNA clone encoding the visna virus transactivating protein. Proc Natl Acad Sci U S A (1989) 1.73
The visna virus genome: evidence for a hypervariable site in the env gene and sequence homology among lentivirus envelope proteins. J Virol (1987) 1.63
Evolutionary trees with minimum nucleotide replacements from amino acid sequences. J Mol Evol (1974) 1.23
EIAV genomic organization: further characterization by sequencing of purified glycoproteins and cDNA. Virology (1988) 0.98
Distinguishing homologous from analogous proteins. Syst Zool (1970) 25.10
Construction of phylogenetic trees. Science (1967) 23.69
Comparative biosequence metrics. J Mol Evol (1981) 21.34
Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature (1988) 10.69
Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature (1988) 10.15
An improved method of testing for evolutionary homology. J Mol Biol (1966) 9.42
Radioiodination of proteins in single polyacrylamide gel slices. Tryptic peptide analysis of all the major members of complex multicomponent systems using microgram quantities of total protein. J Biol Chem (1977) 8.03
Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science (1986) 8.01
Molecular cloning and characterization of avian sarcoma virus circular DNA molecules. J Virol (1980) 7.37
Predicting the evolution of human influenza A. Science (1999) 6.91
A method for estimating the number of invariant amino acid coding positions in a gene using cytochrome c as a model case. Biochem Genet (1967) 6.87
Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants. Proc Natl Acad Sci U S A (1977) 6.80
endo-beta-N-acetylglucosaminidase F: endoglycosidase from Flavobacterium meningosepticum that cleaves both high-mannose and complex glycoproteins. Proc Natl Acad Sci U S A (1982) 6.64
Evidence from nuclear sequences that invariable sites should be considered when sequence divergence is calculated. Mol Biol Evol (1989) 6.60
Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. Proc Natl Acad Sci U S A (1986) 6.57
Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science (1987) 6.56
An estimation of the number of invariable sites is necessary for the accurate estimation of the number of nucleotide substitutions since a common ancestor. Prog Clin Biol Res (1986) 6.34
Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science (1998) 5.83
Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication. Proc Natl Acad Sci U S A (1987) 5.65
Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol (1999) 4.97
Evolution of human influenza A viruses over 50 years: rapid, uniform rate of change in NS gene. Science (1986) 4.64
Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. Genes Dev (1989) 4.63
Location and function of retroviral and SV40 sequences that enhance biochemical transformation after microinjection of DNA. Cell (1983) 4.53
Polymorphism of the major envelope glycoprotein (gp70) of murine C-type viruses: virion associated and differentiation antigens encoded by a multi-gene family. Nature (1977) 4.31
Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J Virol (1997) 4.19
Influenza B virus evolution: co-circulating lineages and comparison of evolutionary pattern with those of influenza A and C viruses. Virology (1988) 4.03
Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am J Vet Res (1988) 3.89
Random sequences. J Mol Biol (1983) 3.72
An examination of the constancy of the rate of molecular evolution. J Mol Evol (1974) 3.68
Experimental transmission of Bartonella henselae by the cat flea. J Clin Microbiol (1996) 3.67
The molecular evolution of cytochrome c in eukaryotes. J Mol Evol (1976) 3.64
An improved method for determining codon variability in a gene and its application to the rate of fixation of mutations in evolution. Biochem Genet (1970) 3.63
A natural classification of the basic helix-loop-helix class of transcription factors. Proc Natl Acad Sci U S A (1997) 3.52
Structural arrangements of transcription control domains within the 5'-untranslated leader regions of the HIV-1 and HIV-2 promoters. Genes Dev (1988) 3.51
Human immunodeficiency virus long terminal repeat responds to T-cell activation signals. Proc Natl Acad Sci U S A (1987) 3.47
Demonstration of peptide:N-glycosidase F activity in endo-beta-N-acetylglucosaminidase F preparations. J Biol Chem (1984) 3.26
Molecular cloning of AIDS-associated retrovirus. Nature (1985) 3.16
Nucleotide sequence of SRV-1, a type D simian acquired immune deficiency syndrome retrovirus. Science (1986) 3.11
Estimating the total number of nucleotide substitutions since the common ancestor of a pair of homologous genes: comparison of several methods and three beta hemoglobin messenger RNA's. J Mol Evol (1980) 3.10
Seroepidemiologic survey of captive Old-World primates for antibodies to human and simian retroviruses, and isolation of a lentivirus from sooty mangabeys (Cercocebus atys). Int J Cancer (1986) 3.09
The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature (1988) 3.07
European swine virus as a possible source for the next influenza pandemic? Virology (1995) 3.07
Comparison of two host cell range variants of feline immunodeficiency virus. J Virol (1990) 2.98
Molecular expression of evolutinary phenomena in the primary and tertiary structures of cytochrome c. Brookhaven Symp Biol (1968) 2.98
Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J Am Vet Med Assoc (1989) 2.97
Locating gaps in amino acid sequences to optimize the homology between two proteins. Biochem Genet (1969) 2.94
Comparative analysis of multiple protein-sequence alignment methods. Mol Biol Evol (1994) 2.91
Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells. Virology (1996) 2.83
Bartonella henselae prevalence in domestic cats in California: risk factors and association between bacteremia and antibody titers. J Clin Microbiol (1995) 2.83
Correlations among amino acid sites in bHLH protein domains: an information theoretic analysis. Mol Biol Evol (2000) 2.81
Primary structure of cholera toxin beta-chain: a glycoprotein hormone analog? Science (1977) 2.66
Considerations regarding the regulation of gene transcription and messenger translation. J Mol Evol (1971) 2.63
Effects of passage history and sampling bias on phylogenetic reconstruction of human influenza A evolution. Proc Natl Acad Sci U S A (2000) 2.42
Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J Virol (1990) 2.40
Evolution of pig influenza viruses. Virology (1991) 2.40
Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice. J Exp Med (1980) 2.38
Gene trees and the origins of inbred strains of mice. Science (1991) 2.35
The role of the lymphatic system in the rejection of homografts: a study of lymph from renal transplants. J Exp Med (1970) 2.34
AIDS retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts. Science (1986) 2.34
Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac. J Virol (1993) 2.26
Differential effects of nef on HIV replication: implications for viral pathogenesis in the host. Science (1989) 2.25
Nucleotide sequence of the envelope gene of Gardner-Arnstein feline leukemia virus B reveals unique sequence homologies with a murine mink cell focus-forming virus. J Virol (1983) 2.24
Insertion sequence-related genetic variation in resting Escherichia coli K-12. Genetics (1994) 2.23
A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J Virol (1994) 2.23
Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. J Immunol (1989) 2.21
Covalent structure of human haptoglobin: a serine protease homolog. Proc Natl Acad Sci U S A (1980) 2.21
9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaques. Antimicrob Agents Chemother (1996) 2.15
Feline immunodeficiency virus infection in cats of Japan. J Am Vet Med Assoc (1989) 2.13
Development of simian immunodeficiency virus isolation, titration, and neutralization assays which use whole blood from rhesus monkeys and an antigen capture enzyme-linked immunosorbent assay. J Clin Microbiol (1991) 2.08
Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Virology (1998) 2.07
Phylogenetic analysis of nucleoproteins suggests that human influenza A viruses emerged from a 19th-century avian ancestor. Mol Biol Evol (1990) 2.07
Sequence relationships of type D retroviruses which cause simian acquired immunodeficiency syndrome. Virology (1987) 2.04
Experimental and natural infection with Bartonella henselae in domestic cats. Comp Immunol Microbiol Infect Dis (1997) 1.99
Evolution of antibiotic resistance genes: the DNA sequence of a kanamycin resistance gene from Staphylococcus aureus. Mol Biol Evol (1983) 1.97
Monoclonal antibodies to three epitopic regions of feline leukemia virus p27 and their use in enzyme-linked immunosorbent assay of p27. J Immunol Methods (1983) 1.94
Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology (1994) 1.94
Mapping the order of DNA restriction fragments. Gene (1983) 1.89
Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus. J Med Primatol (1989) 1.88
Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J Virol (1990) 1.86
An enteric coronavirus infection of cats and its relationship to feline infectious peritonitis. Am J Vet Res (1981) 1.85
Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus. J Virol (1991) 1.83
Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2. J Interferon Res (1986) 1.83
Real-time TaqMan PCR as a specific and more sensitive alternative to the branched-chain DNA assay for quantitation of simian immunodeficiency virus RNA. AIDS Res Hum Retroviruses (2001) 1.82
Animal models of AIDS. FASEB J (1989) 1.82
Activation of PAK by HIV and SIV Nef: importance for AIDS in rhesus macaques. Curr Biol (1996) 1.81
Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria. Virology (1986) 1.81
Distinct subsets of retroviruses encode dUTPase. J Virol (1992) 1.80
Mutants of feline immunodeficiency virus resistant to 3'-azido-3'-deoxythymidine. J Virol (1991) 1.79
Carbohydrate dramatically influences immune reactivity of antisera to viral glycoprotein antigens. Science (1984) 1.77
The phylogenic relationships of some Indian tribes of Central and South America. Am J Hum Genet (1969) 1.77
Outbreak of fatal salmonellosis in cats following use of a high-titer modified-live panleukopenia virus vaccine. J Am Vet Med Assoc (1999) 1.75
Molecular, clinical, and pathologic comparison of two distinct strains of Haemobartonella felis in domestic cats. Am J Vet Res (1998) 1.75
Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections. J Acquir Immune Defic Syndr (1991) 1.75